Caffree Co.
Caffree Co. is a biotech company reinventing decaffeination through proprietary enzymatic technology that converts caffeine directly into theobromine — with no solvents, no third-party facility shipping, and no capital equipment required. Founded by Aryeh Ganz, Dr. Robby Divine, and Dr. Justin Siegel, and led by CEO Eric Quick, Caffree offers tunable caffeine levels and superior flavor preservation versus incumbent processes. The team is backed by a science and industry advisory board spanning Peet's Coffee, Mars Inc., and UC Davis's